{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:29:26Z","timestamp":1778131766162,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT - 162201"],"award-info":[{"award-number":["PJT - 162201"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.contraception.2022.03.020","type":"journal-article","created":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T18:33:06Z","timestamp":1648319586000},"page":"19-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Provision of first-trimester medication abortion in 2019: Results from the Canadian abortion provider survey"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1263-2676","authenticated-orcid":false,"given":"Madeleine","family":"Ennis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7988-0877","authenticated-orcid":false,"given":"Regina","family":"Renner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7764-9076","authenticated-orcid":false,"given":"Edith","family":"Guilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4340-7882","authenticated-orcid":false,"given":"Wendy V","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Pymar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5770-2340","authenticated-orcid":false,"given":"Lauren","family":"Kean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4554-7635","authenticated-orcid":false,"given":"Ruth","family":"Martin-Misener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2284-1364","authenticated-orcid":false,"given":"Sheila","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2022.03.020_bib0001","series-title":"Induced abortions reported in Canada in 2019","year":"2021"},{"key":"10.1016\/j.contraception.2022.03.020_bib0002","first-page":"e201","article-title":"First-trimester medical abortion practices in Canada: National survey","volume":"62","author":"Guilbert","year":"2016","journal-title":"Canadian Fam Phys Med Fam Can"},{"key":"10.1016\/j.contraception.2022.03.020_bib0003","first-page":"e209","article-title":"Abortion health services in Canada: results of a 2012 national survey","volume":"62","author":"Norman","year":"2016","journal-title":"Canadian Fam Phys Med Fam Can"},{"key":"10.1016\/j.contraception.2022.03.020_bib0004","unstructured":"United Nations. Committee on the Elimination of Discrimination against Women: concluding observations on the combined eighth and ninth periodic reports of Canada. http:\/\/www.etoconsortium.org\/nc\/en\/404\/?tx_drblob_pi1%5BdownloadUid%5D=194, Accessed June 18, 2021: United Nations High Commissioner on Human Rights,; 2016."},{"key":"10.1016\/j.contraception.2022.03.020_bib0005","unstructured":"Blaze Baum K. Health Canada eases restrictions on abortion pill Mifegymiso. The Globe & Mail. https:\/\/www.theglobeandmail.com\/news\/national\/health-canada-eases-restrictions-on-abortion-pill-mifegymiso\/article36860275\/ Accessed September 28, 2021: Phillip Crawley; 2017."},{"key":"10.1016\/j.contraception.2022.03.020_bib0006","series-title":"Mifegymiso. Health Canada updates prescribing and dispensing information for Mifegymiso","year":"2017"},{"key":"10.1016\/j.contraception.2022.03.020_bib0007","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bpobgyn.2019.05.010","article-title":"When there are no abortion laws: a case study of Canada","volume":"62","author":"Shaw","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2022.03.020_bib0008","unstructured":"Action Canada for Sexual Health and Rights. FAQ: the abortion pill mifegymiso. https:\/\/www.actioncanadashr.org\/resources\/factsheets-guidelines\/2019-04-06-faq-abortion-pill-mifegymiso. (Accessed December 14, 2021). 2019."},{"key":"10.1016\/j.contraception.2022.03.020_bib0009","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jogc.2016.01.002","article-title":"Medical abortion","volume":"38","author":"Costescu","year":"2016","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.contraception.2022.03.020_bib0010","doi-asserted-by":"crossref","first-page":"e67070","DOI":"10.1371\/journal.pone.0067070","article-title":"The perspective of rural physicians providing abortion in Canada: qualitative findings of the BC Abortion Providers Survey (BCAPS)","volume":"8","author":"Dressler","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.contraception.2022.03.020_bib0011","doi-asserted-by":"crossref","first-page":"e67023","DOI":"10.1371\/journal.pone.0067023","article-title":"Barriers to rural induced abortion services in Canada: findings of the British Columbia Abortion Providers Survey (BCAPS)","volume":"8","author":"Norman","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.contraception.2022.03.020_bib0012","series-title":"Mail and internet surveys: the tailored design method","author":"Dillman","year":"2000"},{"key":"10.1016\/j.contraception.2022.03.020_bib0013","series-title":"49th Annual Meeting of the North American Primary Care Research Group (NAPCRG)","first-page":"2642","article-title":"Development of a fraud detection plan in a survey of Canadian abortion providers","volume":"20","author":"Ennis","year":"2022"},{"key":"10.1016\/j.contraception.2022.03.020_bib0014","series-title":"RStudio: integrated development environment for R","author":"Team","year":"2021"},{"key":"10.1016\/j.contraception.2022.03.020_bib0015","first-page":"17","article-title":"Nurses are key members of the abortion care team: why aren't schools of nursing teaching abortion Care?","volume":"1","author":"Paynter","year":"2019","journal-title":"Witness: Can J Crit Nurs Discourse"},{"key":"10.1016\/j.contraception.2022.03.020_bib0016","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1370\/afm.2562","article-title":"Perspectives among Canadian physicians on factors influencing implementation of mifepristone medical abortion: a national qualitative study","volume":"18","author":"Munro","year":"2020","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.contraception.2022.03.020_bib0017","doi-asserted-by":"crossref","first-page":"i30","DOI":"10.1093\/fampra\/cmab083","article-title":"The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic","volume":"38","author":"Ennis","year":"2021","journal-title":"Fam Pract"},{"key":"10.1016\/j.contraception.2022.03.020_bib0018","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJMsa2109779","article-title":"Abortion safety and use with normally prescribed mifepristone in Canada","volume":"386","author":"Schummers","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2022.03.020_bib0019","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1471-0528.2012.03464.x","article-title":"Who can provide effective and safe termination of pregnancy care? A systematic review","volume":"120","author":"Renner","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2022.03.020_bib0020","series-title":"Regulatory decision summary: MIFEGYMISO","year":"2015"},{"key":"10.1016\/j.contraception.2022.03.020_bib0021","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13012-021-01144-w","article-title":"Pharmacist dispensing of the abortion pill in Canada: diffusion of Innovation meets integrated knowledge translation","volume":"16","author":"Munro","year":"2021","journal-title":"Implement Sci"},{"key":"10.1016\/j.contraception.2022.03.020_bib0022","unstructured":"CART-GRAC (Contraception & Abortion Research Team-Groupe de recherche sur l'avortemont et la contraception). Canadian Abortion Providers Support-Communaut\u00e9 de pratique canadienne sur l'avortement (CAPS-CPCA) Community of Practice. In: CART-GRAC, editor. established 2017 ed. Vancouver, BC, Canada: University of British Columbia; 2017."},{"key":"10.1016\/j.contraception.2022.03.020_bib0023","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2020.04.012","article-title":"Trends in medication abortion provision before and after the introduction of mifepristone: a study of the National Abortion Federation's Canadian member services","volume":"102","author":"Yalahow","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.03.020_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7009a1","article-title":"Abortion Surveillance \u2014 United States, 2019","volume":"70","author":"Kortsmit","year":"2021","journal-title":"MMWR Surveill Summaries"},{"key":"10.1016\/j.contraception.2022.03.020_bib0025","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0140-6736(14)61054-0","article-title":"Clinical follow-up compared with self-assessment of outcome after medical abortion: a multicentre, non-inferiority, randomised, controlled trial","volume":"385","author":"Oppegaard","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2022.03.020_bib0026","series-title":"Mifeprex risk evaluation and mitigation strategy (REMS)","year":"2011"},{"key":"10.1016\/j.contraception.2022.03.020_bib0027","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.contraception.2021.04.002","article-title":"Mifepristone restrictions and primary care: breaking the cycle of stigma through a learning collaborative model in the United States","volume":"104","author":"Calloway","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.03.020_bib0028","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028443","article-title":"Could implementation of mifepristone address Canada\u2019s urban-rural abortion access disparity: a mixed-methods implementation study protocol","volume":"9","author":"Norman","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.contraception.2022.03.020_bib0029","unstructured":"Kirkey S. Home abortion pill about to hit market in Canada, but has already garnered criticism. National Post. National ed. Toronto, Ontario, Canada: PostMedia; 2016."},{"issue":"12","key":"10.1016\/j.contraception.2022.03.020_bib0030","doi-asserted-by":"crossref","first-page":"e003934","DOI":"10.1136\/bmjgh-2020-003934","article-title":"Effectiveness, safety and acceptability of medical abortion at home versus in the clinic: a systematic review and meta-analysis in response to COVID-19","volume":"5","author":"Gambir","year":"2020","journal-title":"BMJ Glob Health"},{"issue":"3","key":"10.1016\/j.contraception.2022.03.020_bib0031","first-page":"190","article-title":"Slow implementation of mifepristone medical termination of pregnancy in Quebec, Canada: a qualitative investigation","volume":"25","author":"Guilbert","year":"2020","journal-title":"Eur J Cont Reprod Health Care"},{"key":"10.1016\/j.contraception.2022.03.020_bib0032","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.2196\/jmir.6.3.e34","article-title":"Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES)","volume":"6","author":"Eysenbach","year":"2004","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.contraception.2022.03.020_bib0033","unstructured":"Statistics Canada. Table 17-10-0135-01 Population estimates, July 1, by census metropolitan area and census agglomeration, 2016 boundaries. https:\/\/doi.org\/10.25318\/1710013501-eng. (Accessed September 15, 2021)."}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782422000786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782422000786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:11:47Z","timestamp":1762117907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782422000786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":33,"alternative-id":["S0010782422000786"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2022.03.020","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Provision of first-trimester medication abortion in 2019: Results from the Canadian abortion provider survey","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2022.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}